Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2025 Earnings Call Transcript
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2025 Earnings Call Transcript November 5, 2025Seres Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.935, expectations were $0.05.

